"Durie, PR" . . "P(NR9448), Z(MZ0FNM2005)" . . . "JAMA-Journal of The American Medical Association" . . "Drumm, M. L." . "Salvatore, F." . "Genetic Modifiers of Liver Disease in Cystic Fibrosis" . "Bell, SC" . "Zou, F." . "transmembrane conductance regulator; alpha-1-antitrypsin deficiency; lung-disease; risk-factors; alpha(1)-antitrypsin deficiency; severity; epidemiology; association; expression; cirrhosis"@en . . . . "Wang, YF" . "Ling, SC" . "Debray, D." . "000269616200025" . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . "Genetic Modifiers of Liver Disease in Cystic Fibrosis" . "10" . "Wainwright, C." . . "Castellani, C." . "Colombo, C." . . "Lange, EM" . "Silverman, LM" . "1"^^ . . "Lacaille, F." . . "Phillips, M. J." . "Castaldo, G." . "Taylor, CJ" . . "Colombo, J. L." . "313"^^ . "316157" . . "302" . "Bourke, B." . . "Corey, M." . . "8"^^ . . . . . . "Fernandez, A." . "Context A subset (approximate to 3%-5%) of patients with cystic fibrosis (CF) develops severe liver disease with portal hypertension. Objective To assess whether any of 9 polymorphisms in 5 candidate genes (alpha(1)-antitrypsin or alpha(1)-antiprotease [SERPINA1], angiotensin-converting enzyme [ACE], glutathione S-transferase [GSTP1], mannose-binding lectin 2 [MBL2], and transforming growth factor beta 1 [TGFB1]) are associated with severe liver disease in patients with CF." . "Genetic Modifiers of Liver Disease in Cystic Fibrosis"@en . "Zielenski, J." . "[C363FAFB46C2]" . . "Genetic Modifiers of Liver Disease in Cystic Fibrosis"@en . . "Hannah, WB" . "RIV/00216208:11130/09:5337!RIV10-MZ0-11130___" . "11130" . "RIV/00216208:11130/09:5337" . "Macek jr., Milan" . "Cipolli, M." . "Zemkov\u00E1, Daniela" . "Wilschanski, M." . "Context A subset (approximate to 3%-5%) of patients with cystic fibrosis (CF) develops severe liver disease with portal hypertension. Objective To assess whether any of 9 polymorphisms in 5 candidate genes (alpha(1)-antitrypsin or alpha(1)-antiprotease [SERPINA1], angiotensin-converting enzyme [ACE], glutathione S-transferase [GSTP1], mannose-binding lectin 2 [MBL2], and transforming growth factor beta 1 [TGFB1]) are associated with severe liver disease in patients with CF."@en . "0098-7484" . "Dorfman, R." . "Wright, FA" . "Rowland, M." . "Knowles, M. R." . "Pace, R. G." . "Friedman, KJ" . . "Bartlett, JR" .